Growing investment in pharmaceutical R&D boosting the UK Drug Discovery Informatics Market

Published: Mar 2021

The UK drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). One of the major factors that [propels the market growth in the country includes significant growth in R&D investment in the pharmaceutical sector. According to the Association of the British Pharmaceutical Industry (ABPI), UK pharmaceutical industry is significantly investing in R&D. The country invested nearly $6.4 billion in 2017. The rising investment in the pharmaceutical sector increases the adoption of advanced analytics solutions for drug discovery as the application of analytics facilitates a cost-effective, innovative, and streamlined R&D process in the pharmaceutical industry.

Browse the full report description UK Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/uk-drug-discovery-informatics-market

Some of the major research institutes working in the area of synthetic biology in the country include the University of Cambridge, University of Edinburgh, The UK’s national industrial center for synthetic biology, and so on. The University of Edinburgh has the UK Centre for Mammalian Synthetic Biology Research. It is working in the field of whole-cell modeling, cell engineering tool generation, high-throughput phenotyping, and CAD & assembly of DNA. Whole-cell modeling has an essential role in drug testing industries, diagnostics, novel therapeutics, protein-based drugs, and regenerative medicine. Therefore, the significant trend towards synthetic biology further increases the demand for analytics tools for drug discovery in the country.  

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Function and by End-User

Key Companies Profiled

Accenture PLC, Dassault Systèmes SE, Eurofins GSC Lux SARL, Evotec SE, Selvita S.A, and others.

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

UK Drug Discovery Informatics Market – Segmentation

By Function

  • Docking
  • Molecular Modeling
  • Libraries and Database Preparation
  • Sequencing and Target Data Analysis
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others (Research Institutes) 

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-drug-discovery-informatics-market